v3.26.3
CONSOLIDATED AND COMBINED CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Oct. 02, 2026
Oct. 03, 2025
Cash flows from operating activities:    
Net income $ 123,500 $ 194,457
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and other impairment charges 92,971 58,731
Net gain on sale of property, plant and equipment (81) (5,697)
Stock-based compensation expense 18,467 12,542
Deferred income tax benefit (21,989) (7,707)
Amortization of debt issuance costs 8,930 1,882
Changes in operating assets and liabilities:    
Trade receivables, net (45,481) (50,381)
Inventories, net (47,321) (28,924)
Accounts payable 33,075 (9,893)
Other operating assets and liabilities (9,054) (1,496)
Net cash provided by operating activities 153,017 163,514
Cash flows from investing activities:    
Purchases of property, plant and equipment (49,700) (27,654)
Proceeds from sale of property, plant and equipment 735 4,731
Acquisitions, net of cash received 1,469,372 439,669
Other investing 0 (539)
Net cash used in investing activities (1,518,337) (462,053)
Cash flows from financing activities:    
Proceeds from issuance of Preferred stock, net 171,097 0
Proceeds from issuance of Common stock, net 139,796 0
Proceeds from borrowings on Senior Notes 1,000,000 0
Payment of debt issuance costs (17,717) 0
Proceeds from borrowings on revolving credit facilities and other 1,021,894 359,591
Repayments of borrowings on Term Loans 0 (10,000)
Repayments of borrowings on revolving credit facilities and other (917,937) (90,442)
Payment of dividends (19,690) (15,821)
Payment of preferred dividends (1,390) 0
Distributions to noncontrolling interest holders (2,160) (3,057)
Other financing (5,687) (13,008)
Net cash provided by financing activities 1,368,206 227,263
Effect of foreign exchange rates on Cash and cash equivalents (101) 40,137
Increase (decrease) in Cash and cash equivalents 2,785 (31,139)
Cash and cash equivalents, beginning of period 185,863 249,358
Cash and cash equivalents, end of period $ 188,648 $ 218,219